POSA163 Estimating the Budget Impact of the Introduction of Filgotinib for the Treatment of Ulcerative Colitis in Spain

Abstract

Authors

X L.U. I Cuervo-Arango G Jutlla G Jones S Sadler

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×